Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

pfizer_credit_flickr__ceiling

Pfizer expands gene therapy operations with acquisition of Bamboo Therapeutics

August 2, 2016 Manufacturing and Production, Research and Development Pfizer, acquisition, bamboo therapeutics, gene therapy

Pfizer has announced that it has acquired gene therapy biotech Bamboo Therapeutics for an initial $150 million, with potential milestone …
News
takeda_tokyo_hq

Phase III success for Takeda in lymphoma drug

August 1, 2016 Manufacturing and Production, Research and Development Adcetris, Seattle Genetics, Takeda, lymphoma

Takeda Oncology and Seattle Generic have announced new Phase III data for trial drug, Adcetris (brentuximab vedotin), in patients with …
News

FDA approves Shire’s haemophilia A treatment system

August 1, 2016 Manufacturing and Production, Research and Development FDA, Shire, adynovate, baxject, haemophilia

Shire has announced that the Food and Drug Administration (FDA) has approved the baxject III reconstitution system for adynovate [antihemophilic …
News
brexit

The impact of Brexit on the pharmaceutical industry: some preliminary considerations

August 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

The outcome of the popular vote cast on 23 June 2016 will be remembered as the start of a new …
Feature
merck_and_co

European Commission approves Zepatier for chronic hepatitis C infection

August 1, 2016 Research and Development, Sales and Marketing

MSD, known as Merck in the US and Canada, has announced that the European Commission has approved Zepatier (elbasvir/grazoprevir) with …
News

Surprise for Seres as shares sent tumbling by Phase II failure

August 1, 2016 Research and Development, Sales and Marketing FDA, clostrodium difficile, seres therapeutics

Seres Therapeutics has presented interim results from an ongoing Phase II trial which has sent company stock spiralling downward, as …
News
a_scientist_at_work_at_sanofis_immunology_laboratory_in_thailand

EMA accepts MMA for rheumatoid arthritis treatment Sarilumab

August 1, 2016 Research and Development, Sales and Marketing EMA, MAA, Regeneron, Sanofi, sarilumab

Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted the Marketing Authorisation Application (MAA) for …
News
GSK image

GSK and Alphabet to create bioelectronics medicines in £540 million partnership

August 1, 2016 Research and Development, Sales and Marketing Alphabet, GSK, Verily, bioelectronic medicine, galvani, google

GlaxoSmithKline and Verily Life Sciences, a division of Google’s parent company Alphabet, have announced a £540 million partnership that will …
News
antiviralresearch

FDA fast tracks Shire’s SHP626 nonalcoholic steatohepatitis drug

July 29, 2016 Research and Development FDA, SHP626, Shire, liver fibrosis, nash, volixibat, volxibat

The Food and Drug Administration (FDA) has granted Fast Track designation to Shire’s SHP626 (volixibat) treatment for patients suffering from …
News

Ulcerative colitis treatment Xeljanz records positive top-line results in Phase III trial

July 29, 2016 Medical Communications, Research and Development Pfizer, Xeljanz, tofacitinib, ulcerative colitis

Pfizer has announced positive top-line results from oral clinical trials for tofacitinib in ulcerative colitis (Octave) sustain, the third Phase …
News
sanofi_hq_reception_close

Earnings drop at Sanofi as it looks for a quick Medivation resolution

July 29, 2016 Medical Communications, Research and Development 2016, Medivation, Q2, Sanofi, earnings

Sanofi has published its earnings results for Q2, which show a fall in sales and profits as their diabetes division …
News
roche_close

Roche urges reform of Cancer Drugs Fund as NICE takes control

July 29, 2016 Medical Communications, Research and Development, Sales and Marketing CDF, Cancer Drugs Fund, NICE, Roche

Roche has warned that cancer patients in England are facing into an “uncertain future” as the new Cancer Drugs Fund …
News

Ashfield provides clarity on the age old debate: ‘Syndicated’ or ‘Dedicated’ field sales?

July 28, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield is understandably well placed to offer a balanced viewpoint on field sales teams. With over 20 years of experience, …
News
Press release
blue_jeans

Strong early data on haemophilia gene therapy boosts Biomarin

July 28, 2016 Medical Communications, Research and Development BioMarin, gene therapy, haemophilia a

Biomarin has presented interim results from a Phase I/II study that is being hailed as positive “proof-of-concept” data for their …
News
astrazeneca_building_white

Cholesterol drugs drag AstraZeneca’s profits down in latest financial results

July 28, 2016 Research and Development, Sales and Marketing 2016, AstraZeneca, Q2, h1, results

AstraZeneca has maintained its financial outlook for 2016, despite its Q2 and H1 results showing sharp falls in core earnings …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025